3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
10
Neoplasm Metastasis
7
Melanoma
5
Neoplasms
4
Thyroid Neoplasms
3
Neurofibromatosis 1
3
Lung Neoplasms
3
Uveal Melanoma
2
Thyroid Cancer, Papillary
2
Pancreatic Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Thyroid Diseases
1
Thymoma
1
Solid Tumours
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neuroma, Acoustic
1
Neurofibrosarcoma
1
Neurofibromatosis 2
1
Neurofibroma, Plexiform
1
Neuroblastoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Meningioma
1
Interventions
Sunitinib
19
Everolimus
17
Bevacizumab
13
aldesleukin
11
Sorafenib
11
Interleukin-2
10
Cyclophosphamide
10
Axitinib
10
Nivolumab
9
fludarabine phosphate
7
fludarabine
7
pembrolizumab
5
Gemcitabine
5
temsirolimus
4
pazopanib
4
Ipilimumab
4
peginterferon alfa-2b
3
durvalumab
3
cabozantinib
3
Radiosurgery
3
Interferon-alpha
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Filgrastim
3
Erlotinib Hydrochloride
3
Cryosurgery
3
vandetanib
2
spartalizumab
2
perflutren
2
ixabepilone
2
chiron
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Kidney Neoplasms
×
AZD 6244
×
Clear all
No trials found.